Correcting deficiency may improve lipid metabolism relevant to metabolic health but not a direct weight loss mechanism
In recent years, social media platforms have been used to study: Chronic diseases Mental health trends Vaccine reactions Medication side effects The recent GLP-1 study demonstrates how artificial intelligence can analyze vast amounts of patient-generated content and identify patterns that might otherwise go unnoticed
How PlexusDx Supports a More Personalized Approach PlexusDx's Precision Peptide Genetic Test may help provide context for how your body's peptide signaling pathways are structured genetically
Against this background, this review examines GLP-1RA-associated changes in eating experience as a multilevel biological phenomenon rather than a uniform taste disorder. We use a sensorylikingwanting framework to organise evidence across peripheral taste signalling, brainstem interoceptive integration, and central reward-related pathways
About 11 months ago, HbA1c was elevated to 9.2%, and treatment was switched from sitagliptin (a dipeptidyl peptidase-4 inhibitor) to tirzepatide weekly subcutaneous injection (first month, 2.5 mg each week
